LS Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
18,240
+4,575
+33% +$369K 0.19% 67
2026
Q1
$1.18M Buy
13,665
+442
+3% +$42.3K 0.18% 74
2025
Q4
$1.27M Sell
13,223
-877
-6% -$85.2K 0.18% 71
2025
Q3
$1.34M Buy
14,100
+825
+6% +$75.8K 0.19% 69
2025
Q2
$1.16M Buy
13,275
+1,450
+12% +$123K 0.17% 77
2025
Q1
$1.06M Sell
11,825
-145
-1% -$13K 0.16% 77
2024
Q4
$956K Buy
11,970
+640
+6% +$55.4K 0.14% 81
2024
Q3
$1.02M Sell
11,330
-1,880
-14% -$158K 0.15% 80
2024
Q2
$1.04M Buy
13,210
+540
+4% +$44.3K 0.16% 81
2024
Q1
$1.1M Buy
12,670
+885
+8% +$75.5K 0.18% 80
2023
Q4
$971K Sell
11,785
-570
-5% -$43.4K 0.17% 79
2023
Q3
$968K Buy
12,355
+1,810
+17% +$152K 0.18% 72
2023
Q2
$929K Buy
10,545
+370
+4% +$31.9K 0.16% 72
2023
Q1
$820K Buy
+10,175
New +$829K 0.15% 76
2022
Q3
Sell
-2,300
Closed -$206K 125
2022
Q2
$206K Hold
2,300
0.04% 125
2022
Q1
$255K Sell
2,300
-42,661
-95% -$4.51M 0.04% 119
2021
Q4
$4.65M Sell
44,961
-32,584
-42% -$3.77M 0.7% 37
2021
Q3
$9.72M Buy
77,545
+1,943
+3% +$251K 1.25% 33
2021
Q2
$9.38M Sell
75,602
-62,693
-45% -$7.87M 1.19% 35
2021
Q1
$16.3M Sell
138,295
-12,355
-8% -$1.45M 0.91% 21
2020
Q4
$17.6M Sell
150,650
-4,392
-3% -$483K 0.93% 19
2020
Q3
$16.1M Buy
155,042
+4,974
+3% +$500K 0.91% 19
2020
Q2
$13.8M Buy
150,068
+8,708
+6% +$835K 0.85% 20
2020
Q1
$12.7M Sell
141,360
-4,545
-3% -$484K 0.92% 19
2019
Q4
$16.6M Sell
145,905
-2,107
-1% -$231K 0.89% 18
2019
Q3
$16.1M Sell
148,012
-2,651
-2% -$277K 0.94% 17
2019
Q2
$14.7M Buy
150,663
+4,718
+3% +$431K 0.89% 19
2019
Q1
$13.3M Sell
145,945
-950
-0.6% -$85K 0.83% 23
2018
Q4
$13.4M Sell
146,895
-10,761
-7% -$1.01M 0.93% 16
2018
Q3
$15.5M Sell
157,656
-10,943
-6% -$1.01M 0.89% 20
2018
Q2
$14.4M Sell
168,599
-29,877
-15% -$2.5M 0.87% 22
2018
Q1
$15.9M Buy
198,476
+8,664
+5% +$715K 0.95% 19
2017
Q4
$15.3M Sell
189,812
-6,463
-3% -$518K 0.89% 21
2017
Q3
$15.3M Sell
196,275
-5,353
-3% -$444K 0.91% 22
2017
Q2
$17.9M Sell
201,628
-924
-0.5% -$77.9K 1.09% 12
2017
Q1
$16.3M Sell
202,552
-860
-0.4% -$67.2K 1.04% 15
2016
Q4
$14.5M Buy
203,412
+5,955
+3% +$468K 1.02% 20
2016
Q3
$17.1M Sell
197,457
-12,988
-6% -$1.13M 1.25% 11
2016
Q2
$18.3M Buy
210,445
+10,634
+5% +$860K 1.26% 10
2016
Q1
$15M Buy
199,811
+13,504
+7% +$1.02M 1.12% 15
2015
Q4
$14.3M Buy
186,307
+14,116
+8% +$1.06M 1.11% 14
2015
Q3
$11.5M Sell
172,191
-2,170
-1% -$160K 0.93% 22
2015
Q2
$12.9M Sell
174,361
-2,408
-1% -$184K 0.96% 26
2015
Q1
$13.8M Buy
176,769
+115,049
+186% +$8.72M 1.05% 24
2014
Q4
$4.46M Sell
61,720
-5,131
-8% -$356K 0.36% 59
2014
Q3
$4.14M Sell
66,851
-18,426
-22% -$1.17M 0.36% 59
2014
Q2
$5.44M Sell
85,277
-1,063
-1% -$64.6K 0.46% 49
2014
Q1
$5.31M Buy
86,340
+17,239
+25% +$1M 0.44% 52
2013
Q4
$3.97M Buy
69,101
+9,805
+17% +$556K 0.36% 63
2013
Q3
$3.16M Buy
59,296
+9,685
+20% +$521K 0.38% 59
2013
Q2
$2.55M Buy
+49,611
New +$2.45M 0.33% 62

Other funds holding MDT

LS Investment Advisors's MDT Position: Q2 2026 in Review

LS Investment Advisors increased its Medtronic (MDT) stake by 33% in Q2 2026, buying an estimated $369K and bringing the position to 18,240 shares worth $1.43M. The position accounts for 0.19% of the portfolio, ranked #67.

LS Investment Advisors first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.3M in Q2 2016. 494 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LS Investment Advisors held 18,240 shares of Medtronic worth $1.43M as of Q2 2026.
  • LS Investment Advisors bought 4,575 Medtronic shares in Q2 2026, an estimated $369K.
  • Medtronic made up 0.19% of LS Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • LS Investment Advisors first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • LS Investment Advisors's Medtronic position peaked at $18.3M in Q2 2016.
  • 494 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LS Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.